๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS ยท Real-Time Price ยท USD
1.370
-0.060 (-4.20%)
Nov 18, 2026, 4:00 PM EST - Market closed

Kalaris Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Income
-46.83-46.15-51.73-13.46-14.01
Net Income
-43.4-43.44-69.17-14.7-15.49
Earnings Per Share
-1.91-2.85-51.77-2.42-3.48
EPS Growth
-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
82.86117.981.643.173.06
Total Debt
-1.4519.91-3.25
Net Cash (Debt)
82.86116.53-18.273.17-0.19
Net Cash Growth
9.81%----
Net Cash Per Share
3.657.63-13.670.52-0.04

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
--38.37-20.67-14.13-9.78
Capital Expenditures
--0.2---
Free Cash Flow
--38.57-20.67-14.13-9.78
Free Cash Flow Growth
-----

Valuation

Selected indicators aren't available for this stock.